ReaLi Tide Biological Technology (Weihai) Co., Ltd. (referred to as RLTBIO), founded in 2016, is a national high-tech enterprise specializing in the R&D, customization, and production of high-tech pharmaceuticals, as well as beauty ingredients such as peptides, polysaccharides, nucleic acids, and modern marine-derived biological materials. RLTBIO operates a green, high-standard production facility spanning over 250,000 m², including 20,000 m² of GMP-compliant clean workshops capable of simultaneously supporting production for seven GMP-certified product lines. RLTBIO has established a comprehensive production system ranging from active pharmaceutical ingredients (APIs) to premium cosmetic raw materials, leveraging its technological strengths to become a long-term strategic CRO/CDMO partner for lots of leading domestic and international pharmaceutical and cosmetic brands. At present the company has established deep collaborations with 2000+ global pharmaceutical and cosmetic enterprises.
RLTBIO is a biopharmaceutical enterprise uniquely equipped with dual technology platforms: liquid-phase/solid-phase peptide synthesis and polysaccharide drugs development. RLTBIO’s independently developed elcatonin API is the first domestically developed and approved product in China, breaking the monopoly of imported alternatives.Leuprorelin acetate API has obtained national GMP certification, filling a technological gap in Shandong Province. Additionally, five APIs—including leuprorelin acetate and semaglutide—have completed U.S. FDA filings and received Drug Master File (DMF) numbers, marking critical breakthroughs in RLTBIO’s global expansion within the high-end API sector.
